Surgical resection of early stage nonsmall cell lung cancer (NSCLC) is necessary for cure. However, rates of postoperative bacterial pneumonias remain high and may confer an increased risk for metastasis. Toll-like receptors (TLRs) mediate the inflammatory cascade by recognizing microbial products at the surface of numerous cell types in the lung; however, little is known about how host TLRs influence NSCLC metastasis. TLR2 recognizes gram-positive bacterial cell wall components activating innate immunity. We demonstrate that lower respiratory tract infection with Streptococcus pneumonia augments the formation of murine H59 NSCLC liver metastases in C57BL/6 mice through host TLR2 activation. Infected mice demonstrate increased H59 and human A549 NSCLC adhesion to hepatic sinusoids in vivo compared with noninfected controls, a response that is significantly diminished in TLR2 knock-out mice. Intra-tracheal injection of purified TLR2 ligand lipoteichoic acid into mice similarly augments in vivo adhesion of H59 cells to hepatic sinusoids. Additionally, H59 and A549 NSCLC cells incubated with bronchoepithelial conditioned media show increased cell adhesion to extracellular matrix components in vitro and hepatic sinusoids in vivo in a manner that is dependent on bronchoepithelial TLR2 activation and interleukin-6 secretion. TLR2 is therefore a potential therapeutic target for gram-positive pneumonia-driven NSCLC metastasis.
surgery, many NSCLC patients will suffer from hematogenous metastatic recurrence and eventually die from their cancer. 4 The morbidity and mortality associated with NSCLC metastasis makes its prevention a clinical problem of utmost importance. Tumor manipulation during surgery can trigger the dissemination of cancer cells into the bloodstream acting as a source of future distant metastases. 4 Additionally, tissue damage during surgery triggers a systemic inflammatory response which can act as a fertile environment for cancer metastasis and tumor growth. 5 Exacerbating the systemic inflammatory response of thoracic surgery are high rates of postoperative infectious complications, predominantly bacterial pneumonias, occurring in as many as 25-40% of patients. 6, 7 There is strong clinical data suggesting that postoperative pulmonary infections result in significant reductions in five-year overall survival 8, 9 and five-year cancer-specific survival for NSCLC patients. 8 The association between infectious complications following tumor resection and metastasis has similarly been demonstrated across a number of other solid organ tumours. [10] [11] [12] [13] [14] The mechanisms for this interaction between postoperative infection and adverse oncologic outcomes are not entirely certain.
Microbial pattern recognition receptors (PRR) including
Toll-like receptors (TLRs) have been implicated in cancer progression in a number of in vitro and in vivo studies. [15] [16] [17] [18] However, a limitation of these previous reports is the use of purified bacterial structures, which do not accurately replicate the clinical scenario of postoperative pulmonary infection analyzed in the population-based studies. Additionally these studies did not determine whether host TLRs can augment cancer metastasis in the context of an in vivo infectious model. For these reasons we elected to investigate the effects of murine gram-positive bacterial pneumonia, a physiologically and pathologically relevant infectious model, on NSCLC metastasis.
During bacterial pneumonia, virulent gram-positive and/or gram-negative bacteria multiply and damage the host respiratory tract. 6 The respiratory epithelium acts as a mechanical barrier to these invasive bacteria 19 and also serves a sentinel immunological function through the expression of various TLRs. 19, 20 TLRs form a family of evolutionarily ancient PRR that recognize the presence of conserved pathogen-associated molecular patterns (PAMPs) and activate the innate immune system. 21 Human respiratory epithelial cell-surface expression of TLRs 1-6 has been verified. [22] [23] [24] In the context of pneumonia, TLR2 is a primary PRR that recognizes invading gram-positive bacteria. 21 Cell wall-associated PAMPs such as lipoteichoic acid (LTA) and diacylated lipoproteins are recognized by TLR2-TLR6 heterodimers (TLR2/6). Upon activation, TLR2 predominantly signals through cytosolic adaptor protein MyD88 leading to the activation of NF-jB and Mitogen-Activated Protein Kinases. 21 Respiratory epithelium TLR activation induces the secretion of IL-6 and IL-8, which have potent pro-inflammatory and chemotactic effects. 24, 25 IL-6 binds to soluble or membrane-bound IL-6 receptor and signals through membrane-bound gp130 activating transcription factor STAT3 which, in turn, stimulates cancer proliferation, survival, immune evasion and angiogenesis. 26 Previous work has demonstrated that versican secreted by Lewis Lung Carcinoma (LLC) cells acts as a promoter of metastatic growth in vivo through host TLR2 activation. 27 Based on these observations we hypothesized that gram-positive pneumococcal pneumonia would increase the formation of in vivo gross NSCLC hepatic metastases in mice through host TLR2 activation in part through augmenting systemic cancer cell adhesion. To this end, we employed intranasally inoculated Streptococcus pneumonia D39 (serotype 2), a well-established murine model of gram-positive pneumonia in C57Bl6 mice. 28, 29 Its virulence as a murine pathogen is strongly attributable to its capsule allowing it to avoid entrapment in respiratory mucous, with non-encapsulate strains of S. pneumonia demonstrating impaired pathogenic ability. 30 In this context, TLR2-deficient mice demonstrate delayed respiratory tract pneumococcal bacterial clearance secondary to a blunted innate immune response. 31 We therefore additionally hypothesized that bronchoepithelial TLR2 activation would augment the secretion of inflammatory cytokines, including IL-6, that will enhance murine and human NSCLC adhesion to extracellular matrix components in vitro and hepatic sinusoids in vivo.
Materials and Methods

Animals
Seven to ten week-old male mice (20-25 g) were bred and maintained in the Montreal General Hospital Animal Facility. C57BL/6 mice were obtained from Charles River Labs (St. Constant, Canada). TLR2
-/-, TLR4 -/-and MyD88
-/-mice on a C57BL/6 background were obtained from Dr. Michel Chignard (Pasteur Institute, Paris, France) and their genotypes were verified by PCR analysis of ear-punch DNA. Mice were anesthetized as previously described 20 by intraperitoneal injection or via inhaled isoflurane (Baxter, Mississauga, Canada). All animal experiments were conducted in accordance with local institutional guidelines and were approved by the McGill University Animal Care Committee.
Bacterial culture
Streptococcus pneumoniae serotype D39 (D39) (NCTC 7466) was obtained from the Public Health England Culture Collection (Salisbury, UK). D39 bacteria were cultured in Todd-Hewitt Broth (BD Biosciences, USA) with 20% Fetal Bovine Serum (FBS; Wisent, Canada) until the mid-log phase of growth and 1 ml aliquots were subsequently snap-frozen in liquid N 2 and maintained frozen at 2808C. The number of viable colony forming units (CFU) per ml of frozen sample stock were counted in three separate vials by streaking thawed frozen aliquots on Columbia Blood Agar (CBA; Thermo Scientific) after 24 hr of incubation at 378C and 5% CO 2 . For heat-inactivated bacteria experiments, D39 were heated at 958C for 10 min and cooled to room temperature before use.
Intranasal pneumonia model
Frozen aliquots of D39 were thawed and diluted to a concentration of 3 3 10 5 CFU/ml using sterile PBS and 50 ll of this stock solution was intranasally inoculated into anesthetized male mice. Mice were placed under a heat lamp and observed until recovery from anesthesia. CFU/ml of the bacterial stock solution was verified through streaking and culture on CBA.
Intratracheal injection
Mice were anesthetized with inhaled isofluorane and placed supine. A transverse skin incision was performed over the trachea. Subsequently, the salivary glands were bluntly dissected using forceps to expose the trachea and a 28-gauge needle at a 458 angle was used to inject 50 ll of either sterile PBS or LTA What's new? Toll-like receptors (TLRs) serve a role in microbial recognition at the cell surface in the lung. In non-small cell lung cancer (NSCLC), however, TLRs are suspected of contributing to post-operative bacterial pneumonia, which potentially increases metastatic risk. This study demonstrates in mice that the presence of Streptococcus pneumonia in the lower respiratory tract in fact augments NSCLC liver metastasis. By comparison, metastases were diminished in TLR2 knockout animals, while intratracheal administration of TLR2-activating ligand triggered metastasis following H59 cell injection in wild-type animals. The findings suggest that TLR2 is a promising target for the treatment of gram-positive pneumonia-associated NSCLC metastasis. suspended in PBS (2 lg/ml, 100 lg/mouse) into the tracheal lumen. The skin incision was then closed using a figure-ofeight stitch with 5-0 Vicryl (Ethicon).
Antibodies and reagents
Rat poly-clonal IgG TLR2 function-blocking antibody and isotype control rat poly-clonal IgG were purchased from InvivoGen, USA. Streptococcus pneumonia-derived LTA was purchased from Sigma-Aldrich, Canada. Collagen I, collagen IV and fibronectin were purchased from Roche Applied Science, USA. Interleukin-6 (IL-6) neutralizing antibody and monoclonal mouse IgG1 isotype control antibody were purchased from R&D Systems, USA. Human recombinant (HR) IL-6 was purchased from EMD Millipore, Canada.
Cell culture methods
LLC subline H59 6 stably expressed GFP after plasmid transfection, were tested for contaminants and authenticated in accordance with our institutional policies using PCR within the past year. A549 human lung adenocarcinoma cells were obtained from the American Type and Culture Collection (ATCC) via Cedarlane Labs, Canada within the past 3 years. Human immortalized bronchoepithelial BEAS-2B cells were purchased from the ATCC within the past year. BEAS-2B cells were maintained in a subconfluent state using DMEM high glucose media (4.5 g/l) supplemented with 10% FBS and 1% Penicillin/Streptomycin. Incubation was performed at 378C with 5% CO 2 . Cells were cultured and maintained in a subconfluent state and detached as previously described. 20 All cell culture reagents were purchased from Wisent. All cells were passaged for fewer than six months following authentication/resuscitation.
Preparation of bronchoepithelial conditioned media (BCM)
BEAS-2B cells were grown to 80% confluence in DMEM high glucose media with 10% FBS. BEAS-2B cells express functional TLR2. 32 Cells were then stimulated with LTA or heatinactivated D39 (with or without addition of TLR2 functionblocking antibody or isotype control) for 2 hr. Cells were then washed twice in PBS and serum-free DMEM high glucose media was added. Twenty-four hours later BCM was collected and frozen in 1 ml cryovials (Corning). LTA was used at a final concentration of 1 lg/ml and heat-inactivated D39 was used at a final concentration of 1 3 108 CFU/ml. Both LTA and D39 conditions were also performed with or without TLR2 function-blocking antibody (8 lg/ml) or isotype control antibody (8 lg/ml). Antibodies were added to serum-free media 30 min prior to incubation with LTA or heat-inactivated D39 and remained in the media during stimulation.
Cell culture incubation conditions
NSCLC cells were incubated with thawed BCM for a period of 4 hr prior to detachment and use for extracellular matrix adhesion assays and intravital microscopy (IVM). For IL-6 depletion experiments, a neutralizing antibody, or isotype control were added to LTA BCM at a concentration of 2 lg/ ml 30 min prior to coincubation with NSCLC cells. For the HR IL-6 condition, serum-free DMEM high glucose media was supplemented with HR IL-6 at a concentration of 10 ng/ ml. Following incubation, A549 cells were stained with CFSE (Molecular Probes) for 10 min prior to experiments.
Quantitative IL-6 ELISA Thawed BCM was quantitatively analyzed for IL-6 concentration using a human IL-6 Quantikine ELISA kit (R&D Systems) and was performed according to manufacturer's specifications.
Extracellular matrix adhesion assay
Extracellular matrix adhesion assays to collagen 1, collagen 4 and fibronectin were performed in 96-well plates and analyzed as described previously. 20 Image acquisition was performed using a Nikon TE300 inverted fluorescence microscope and captured using a digital camera (Nikon D90).
Intravital microscopy
Hepatic fluorescence IVM was performed as previously described. 20 Briefly 5x10 4 H59-GFP or A549 cells in 100 lL of PBS were injected once intrasplenically after removal of the abdominal wall. For each animal, ten minutes post-injection the numbers of adherent fluorescent cancer cells in 10 random microscope fields along the liver edge were counted. Image acquisition was performed using a 203 microscope objective of an inverted fluorescent microscope (Nikon TE300) and a digital SLR camera (Nikon D90). Animals were maintained at 378C via infrared heat lamp during the experiment.
Hepatic metastasis assay
Hepatic metastasis assays were performed as previously described on postpneumonia inoculation day three. 20 Briefly 3 3 10 4 H59 cells in 100 ll of PBS were intrasplenically injected once and splenectomy performed one minute postinjection. Mice were sacrificed 2 weeks later and gross liver metastases counted.
Statistical analysis
Statistical analysis and graph production were performed using GraphPad Prism 6 softwareV C (GraphPad Software USA). Numerical data was analyzed using the student's t test or one-way ANOVA with Tukey's HSD post hoc analysis. Data points greater than three standard deviations (SD) from their group mean were excluded from analysis. Statistical significance was defined as p < 0.05. Data are graphically represented as mean 6 SEM for bar graphs and mean 6 SD for metastasis experiments. All experiments were performed a minimum of three times independently.
Results
Gram-positive pneumonia augments murine H59 NSCLC liver metastasis in vivo through TLR2 activation Given the clinical data suggesting a link between pneumonia and NSCLC cancer metastasis we sought to determine if C57BL/6 mice infected intranasally with S. pneumonia D39
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would develop increased NSCLC liver metastases after intrasplenic injection compared with sham inoculated (PBS) mice. C57BL/6 mice with gram-positive pneumonia demonstrated a six-fold increase in murine H59 NSCLC hepatic metastases compared with sham (PBS) inoculated mice (p < 0.05; Fig. 1 ). To investigate whether TLR2 activation contributed to this increase in H59 hepatic metastases, the experiment was repeated in C57BL/6 TLR2 -/-mice. TLR2 -/-mice with gram-positive pneumonia demonstrated a two-fold increase in hepatic metastases compared with sham inoculation (pNS); however, this change was significantly lower compared to the increase in WT infected mice (p < 0.05). As a control condition the experiment was repeated using C57BL/6 TLR4 -/-mice. Similar to WT mice, TLR4 -/-mice with gram-positive pneumonia demonstrated a significant four-fold increase in H59 liver metastases compared with TLR4 -/-noninfected controls and an approximate three-fold decrease in liver metastases compared to infected TLR2 -/-mice (p < 0.05).
Gram-positive pneumonia increases murine H59 and human A549 NSCLC cell adhesion to murine hepatic sinusoids in vivo through TLR2 activation
Early adhesive events are an important step in the formation of hematogenous metastases, 33 and using hepatic IVM we have previously demonstrated that early adhesion is directly related to metastatic ability in LLC cells. 34 To investigate if mice infected with gram-positive pneumonia exhibit increased levels of NSCLC cell adhesion to liver sinusoids in vivo, hepatic fluorescence IVM was employed three days after intranasal inoculation of S. pneumonia D39. WT male mice with grampositive pneumonia demonstrated a four-fold increase in murine H59 cell adhesion to hepatic sinusoids compared with uninfected controls (p < 0.05; Fig. 2a ). In contrast TLR2
-/-mice with gram-positive pneumonia had no significant increase in H59 cell adhesion compared to non-infected TLR2 -/-controls. Infected TLR4 -/-mice that express functional TLR2 demonstrated a 2.5-fold increase in H59 cell adhesion compared with uninfected TLR4 -/-controls (p < 0.05). To demonstrate this result was not specific to the H59 cell line, the experiment was repeated using CFSE-labelled human A549 NSCLC cells ( Intratracheal injection of LTA increases adhesion of H59 murine NSCLC to hepatic sinusoids in vivo through TLR2-dependent MyD88 signalling
After demonstrating the role of TLR2 activation in the increased systemic NSCLC cell adhesion in mice with gram-positive pneumonia, we sought to determine if intratracheal injection of LTA, a purified TLR2-activating ligand, would have a similar effect. C57BL/6 WT, TLR2 -/-and TLR4 -/-mice were intratracheally injected with purified LTA or PBS. Four hours after the intratracheal injection, H59 cells were intrasplenically injected and IVM was performed 10 min later. Both WT and TLR4
-/-male mice demonstrated a significant increase in H59 cell adhesion to hepatic sinusoids in vivo following intratracheal LTA compared with PBS inoculation (p < 0.05; Fig. 3 ). In contrast TLR2
-/-mice did not demonstrate any significant increases in H59 cell adhesion following intratracheal injection of LTA (pNS). To further elucidate the signalling pathway responsible for this increase in NSCLC cell adhesion, the experiment was repeated using MyD88 -/-mice. Similar to TLR2 -/-mice, MyD88 -/-mice injected intratracheally with LTA did not demonstrate a significant increase in H59 cell adhesion to hepatic sinusoids compared with PBS inoculation (pNS) suggesting a TLR2-MyD88 dependent signaling pathway is necessary for augmented NSCLC adhesion associated with gram-positive pneumonia.
TLR2-activated BCM augments murine H59 NSCLC cell adhesion to extracellular matrix components in vitro and murine hepatic sinusoids in vivo After identifying the important contribution of TLR2 activation to increased NSCLC adhesion in mice with gram-positive pneumonia, we hypothesized that the bronchoepithelium secretes inflammatory cytokines that could augment the metastatic capability of NSCLC cells. In order to address this possibility, we created an in vitro model to dissect the relationship between bronchoepithelial TLR2 activation and NSCLC metastasis. BEAS-2B bronchoepithelial cells were stimulated in vitro with TLR2-activating LTA or heat-inactivated S. pneumoniae, washed twice with PBS and incubated in serum free media for 24 hr to create BCM. A rat polyclonal IgG antibody was used to block TLR2 activation on BEAS-2B cells for some conditions. Murine H59 cells were coincubated with various conditions of BCM for four hours prior to detachment. Extracellular matrix adhesion assays to collagen 1 (Fig. 4a), collagen 4 (Fig.  4b) and fibronectin (Fig. 4c) were then performed in vitro. Incubation of murine H59 cells in vitro with TLR2-activating LTA or S. pneumoniae BCM significantly increased H59 cell adhesion to collagen 1, collagen 4 and fibronectin in vitro (p < 0.05). Exposure of the bronchoepithelium to a TLR2 function-blocking antibody significantly diminished this effect (p < 0.05). To determine if this increased adhesion phenotype occurs in vivo, hepatic fluorescence IVM was performed using BCM-stimulated H59 cells (Fig. 4d) . Similar to the in vitro 
results, incubation of H59 cells with LTA or S. pneumoniae BCM resulted in a significant increase in H59 adhesion to hepatic sinusoids (p < 0.05) while blockade of TLR2 on the bronchoepithelium abrogated the augmented cell adhesion phenotype for both LTA and S. pneumoniae BCM conditions (p < 0.05).
TLR2-activated BCM increases murine H59 and human A549 NSCLC adhesion to extracellular matrix components in vitro through IL-6 secretion
Given that MyD88-dependent TLR signalling augments IL-6 secretion by BEAS-2B cells, 25, 35 we hypothesized that IL-6
could have mechanistic importance in the proadhesive effects of TLR2-activated BCM. To evaluate this possibility thawed BCM of various conditions was analysed for IL-6 concentration by ELISA (Fig. 5a) . Importantly, incubation of BEAS-2B cells with LTA or S. pneumoniae resulted in significantly increased BCM IL-6 levels (p < 0.05) that was negated by coincubation with TLR2 function-blocking antibody. Subsequently, extracellular matrix adhesion assays to collagen 1, collagen 4 and fibronectin were repeated for H59 (Fig. 5b) and A549 (Fig. 5c ) cells after addition of IL-6 function-blocking mouse monoclonal IgG1 to LTA BCM. In certain cases HR IL-6 was also used. Neutralization of IL-6 in LTA BCM significantly diminished the increased NSCLC cell adhesion induced by LTA BCM (p < 0.05) while HR IL-6 significantly increased H59 and A549 cell adhesion to all extracellular matrix components (p < 0.05).
TLR2-activated BCM augments murine H59 and human A549 NSCLC adhesion to hepatic sinusoids in vivo through IL-6 secretion Hepatic fluorescence IVM was performed to determine if IL-6 neutralization in LTA BCM was also associated with decreased NSCLC cell adhesion in vivo. The increased in vivo adhesion to hepatic sinusoids observed for LTA BCM coincubated murine H59 (Fig. 6a ) and human A549 (Fig. 6b) cells was abrogated by IL-6 depletion (p < 0.05). Conversely, incubation of H59 and A549 cells with HR IL-6 led to significant increased adhesion to hepatic sinusoids (p < 0.05).
Discussion
Lung cancer remains the leading cause of cancer-related death in North America today accounting for 165 000 deaths annually in the United States. 1 While early-stage NSCLC can be cured by surgical resection of the primary tumor and draining lymph nodes, the majority of NSCLC patients will recur and die of metastatic disease. 4 Compounding this risk of NSCLC metastasis is a high incidence of postoperative pulmonary infectious complications, predominantly pneumonias. Postoperative pneumonias occur in as many as 25-40% of patients following lobectomy for NSCLC. 6, 7 Bacterial pneumonias induce a systemic inflammatory response, 36, 37 which is hypothesized to create favorable conditions for circulating tumor cells (CTCs) to form stable hematogenous metastases leading to earlier NSCLC recurrence and death from metastatic disease. 8, 9 However, the mechanisms by which pneumonia augments NSCLC metastasis remain uncertain.
There are multiple different hypotheses to explain how severe postoperative infectious complications such as pneumonia can contribute to cancer metastasis. In the context of bacterial sepsis, neutrophil extracellular traps (NETs), known for sequestering and killing bacteria, can adhere to CTCs in multiple organ sites and facilitate the development of stable metastases. 38 Previous metastasis literature has focused on the mechanisms whereby cell-surface TLRs on various solid tumor types, such as NSCLC, 20 colorectal cancer, 16 esophageal cancer, 15 breast cancer 18 and melanoma 17 can enhance and augment metastasis. However, healthy host tissue is in much greater abundance than malignant tissue in solid cancer patients and expresses TLRs that play a key role in the host immune response to infection. 39 Therefore, it is highly probable that host cell TLRs play an important role in the connection between severe postoperative infectious complications and solid cancer metastasis.
Herein, we utilized a physiologically relevant model of S. pneumoniae D39 pulmonary infection to investigate whether gram-positive bacterial pneumonia can augment NSCLC metastasis in vivo and to determine if host TLR activation contributes to this pathologic response. We have established for the first time that gram-positive pneumonia can augment the formation of murine NSCLC gross liver metastases in C57BL/6 WT mice compared with noninfected controls. This lends direct support to clinical data from NSCLC patients, suggesting an intimate relationship between post-operative pneumonias and NSCLC metastasis. 8, 9 In contrast TLR2
-/-mice infected with gram-positive pneumonia did not demonstrate a significant increase in gross NSCLC liver metastases, implicating TLR2 activation as an important mechanistic 
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event in this process. Infected TLR4 -/-mice that are unable to respond to LPS from gram-negative bacteria, yet express functional TLR2, demonstrated a similar increase in NSCLC metastases as WT mice when compared to negative controls. Given that murine host TLR2 activation in vivo generates a systemic inflammatory response 40 we hypothesized that TLR2 -/-mice with gram-positive pneumonia would generate lower levels of systemic inflammation and thereby reduced NSCLC metastasis compared with WT mice. This hypothesis is supported by human clinical data using intravenously delivered TLR2 function-blocking antibodies, where ex-vivo blood samples demonstrate diminished inflammatory cytokine release following coincubation with heat-killed gram-positive bacteria. 41 Cancer cell adhesion is a critical step in the formation of hematogenous metastases. 33 We demonstrate that grampositive pneumonia can augment murine and human NSCLC adhesion to hepatic sinusoids in vivo dependent on TLR2 activation. We additionally discovered that NSCLC adhesion to hepatic sinusoids could be similarly augmented following the intra-tracheal administration of purified TLR2/6 activating ligand LTA in a manner that is dependent on TLR2 and its adaptor protein MyD88. The airway is home to multiple cell types including respiratory epithelial cells, endothelial cells and alveolar macrophages (AM), 21 which are possible mediators of this augmented systemic cancer adhesion. Previous airway inflammation experiments following the intra-tracheal injection of LPS, a TLR4-activating ligand, identified hematopoietic cells as important mediators for neutrophil recruitment. This response was in part dependent on AMs as infusion of TLR41/1 AMs partially restored the defective phenotype in TLR4 -/-mice. 42 Given the large amounts of neutrophil chemoattractant IL-8 secreted by TLR4-activated bronchoepithelial cells 25 however, it is plausible that respiratory epithelial cells also play a significant role in TLR-induced airway inflammation. By focusing attention to the respiratory epithelium in pneumonia, we have demonstrated the importance of bronchoepithelial cell TLR2 activation in augmenting murine H59 and human A549 NSCLC adhesion. Following co-incubation with TLR2-activated BCM, H59 and A549 cells exhibit increased adhesion to extracellular matrix components in vitro and hepatic sinusoids in vivo. We identified IL-6 as the predominant cytokine mediating these effects in our model through IL-6 neutralization experiments. IL-6 has been previously implicated in the induction of NSCLC epithelial-mesenchymal-transition, invasion and metastasis. 43 IL-6 is of significant clinical and prognostic importance for NSCLC patients. Elevated serum levels of IL-6 have been associated with decreased survival, 44 increased risk of post-operative metastatic recurrence 45 and poor chemo-responsiveness. Elevated IL-6 production following LPS stimulation of ex-vivo peripheral blood samples in metastatic NSCLC patients is significantly associated with worsened progression-free survival and overall survival. 46 Additionally, high NSCLC STAT-3 and phospho-STAT3 staining, a downstream IL-6 transcription factor, is a poor prognostic indicator for NSCLC patients. 47 Moreover, IL-6 is a central cytokine in the context of in vivo pneumonia. Pneumococcal pneumonia amplifies IL-6 Figure 6 . TLR2-activated BCM augments H59 and A549 NSCLC adhesion to hepatic sinusoids in vivo through IL-6 secretion. (a) H59 and (b) A549 cells were coincubated with BCM in vitro for 4 hr. IL-6 neutralizing antibody was added to LTA-stimulated BCM to determine its influence on NSCLC adhesion. Following coincubation cells were detached and injected intrasplenically in C57BL/6 mice and hepatic IVM performed. HR IL-6 was added to serum-free media as a positive control condition. Neutralization of IL-6 in LTA-stimulated BCM abrogated the increased adhesion seen for LTA-stimulated BCM. * p < 0.05 compared with media condition as determined by one-way ANOVA with Tukey's HSD post-hoc analysis. Data are represented as mean 6 SEM. (a, b) Graphs represent pooled data from three independent experiments, three mice per group (n 5 9 mice per group).
Tumor Immunology and Microenvironment levels in lung tissue and plasma and has previously been linked to increased hepatic acute phase protein synthesis through IL-6 induction. 48 Surgical patients that develop postoperative pneumonia similarly develop an exacerbated systemic inflammatory response following surgery associated with elevated serum IL-6. 36 Early postoperative elevations in IL-6 have also been identified as a predictor for postoperative pneumonia. 36 Our identification of gram-positive pneumonia as catalyst for the formation of NSCLC metastasis in vivo through host TLR2 activation is supported by previous work by Kim et al. In contrast to our infectious model of gram-positive pneumonia as a TLR2-activating stimulus, Kim et al. identified LLCsecreted versican as a TLR2-mediated stimulator of in vivo metastasis in mice, highlighting the importance of host TLR2 in the context of cancer cell-induced inflammation. 27 Utilizing their metastasis model comprised of non-infected C57BL/ 6 mice with LLC delivered via tail vein or subcutaneous injection they subsequently identified bone-marrow derived cells as important mediators of versican/host TLR2-stimulated metastasis. Notably our hepatic metastasis data utilizing LLC variant H59 at 14 days postintrasplenic injection does not demonstrate a significant difference between sham PBS inoculated WT and TLR2 -/-mice. This difference may be attributable to our use of the H59 LLC variant, which preferentially metastasizes to liver over lung, 49 compared to the LLC employed by Kim et al., which formed relatively few hepatic metastases at 48 days post tail vein inoculation. It is also possible that a protracted incubation period following intrasplenic injection of H59 cells could delineate a reduction in tumor burden in sham inoculated TLR2 -/-compared with WT mice.
As a mechanistic explanation for the versican/TLR2-mediated increase in LLC metastasis, Kim et al. demonstrate a significant metastasis reduction in TNFa -/-mice compared to WT mice. 27 This explanation is supported by host and LLC cell surface TNFR2 activation leading to increased murine LLC tumor burden in vivo. 50 However, a reduction in cancer-specific mortality, a consequence of pulmonary tumor burden, was not witnessed in WT mice compared to IL-6 -/-mice. 27 IL-6 is a negative regulator of TNFa secretion. 51 Moreover murine IL-6 neutralization in vivo can increase systemic TNFa levels 52 highlighting a possible explanation for lack in reduction of LLC cancer-specific morality witnessed in IL-6 -/-mice using their model. The current study highlights the possibility of inhibiting the identified inflammatory pathways with the goal of diminishing NSCLC metastasis triggered by gram-positive pneumonia. Function-blocking antibodies are currently being investigated in phase I/II clinical trials for TLR2 41 and IL-6, 53 and may represent future therapeutic options to combat infectious complication-triggered NSCLC metastasis. Importantly, the TLR4 inhibitor Eritoran has been utilized in a stage III randomized control trial of severe sepsis patients and did not augment mortality risk. 54 This suggests that antiinflammatory therapies, in combination with concurrent standard medical treatments for infection, could help reduce cancer metastasis augmented by severe infectious complications. The optimal timing for the introduction of such interventions however has yet to be elucidated.
In conclusion, gram-positive pneumococcal pneumonia can augment NSCLC metastasis through host TLR2 activation. This is mediated in part through respiratory epithelium TLR2 activation and IL-6 secretion. TLR2 is therefore a potential therapeutic target to decrease gram-positive pneumonia-driven NSCLC metastasis.
